Document is current
Any future updates will be listed below
-
Authors
Martin, Leonardo https://orcid.org/0000-0003-3524-4876
Gabbiani, Giulio
De Meyer, Guido R Y https://orcid.org/0000-0003-3848-8702
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (101095426)
Universiteit Antwerpen (0001-26557)
- License Information
-
More Information
Article History
Received: 21 May 2025
Revised: 15 July 2025
Accepted: 17 July 2025
First Online: 31 July 2025
Disclosure and competing interests statement
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Mast cells as effectors in hemorrhage and acute cardiovascular diseases (MASTer Consortium) approved by the European Granting Authority as part of the ERA4Health Joint Transnational Call “Research targeting development of innovative therapeutic strategies in cardiovascular disease” (CARDINNOV/2023) program. ERA4Health_EU Network (ERA-NET), Funded by the European Union under the Horizon Europe Framework Programme (Horizon_EU), Co-funded by The Research Foundation – Flanders (FWO).
